Quantumzyme, a biotransformation company, focused on clean and green chemistry has recently been granted a patent for the transaminase enzyme by applying its revolutionary technology QZyme Workbench ...

Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), ...

The Sports Medicine Unit at Sir Ganga Ram Hospitals and A+ Orthopaedic and Sports Med Centre, Delhi, recently conducted the 19th Sports Medicine Arthroscopy Workshop in association with the Indian ...

Huma Therapeutics (Huma), a leading global digital health company, announced that it has become the only company in the world to receive EU MDR 2017/745 Class IIb certification for a disease agnostic ...

Finnish medical technology company Askel Healthcare is developing a new method to treat knee cartilage defects. Askel Healthcare’s Copla implant is expected to significantly accelerate rehabilitation ...

On the occasion on World TB Day, the World Health Organization (WHO) is announcing the expanded scope of the WHO Director-General’s (DG) Flagship Initiative on tuberculosis over the period from 2023 ...

Indian healthcare providers and pharma companies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB ...

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been conditionally approved in China for the treatment of adult patients with mantle ...

The primary and all key secondary endpoints were met in a phase 3 trial evaluating the investigational use of Dupixent (dupilumab) compared to placebo in adults currently on maximal standard-of-care ...

There has been limited knowledge of the molecular genetic underpinnings of addiction until now. Further, most clinical trials and behavioural studies have focused on individual substances, rather than ...

Systematic tracking approach followed by testing is a must in order to curb the spread of tuberculosis (TB), particularly in remote areas where regular medical services are unavailable, according to ...

Even as every year 2.2 lakh patients develop end-stage renal disease (ESRD), which required the patient to undergo dialysis, the key challenges including the lack of access to dialysis centres and ...